文献速递甲状腺与颈部外科围术期管理与 ERAS

顺阿曲库铵与罗库溴铵对机器人BABA甲状腺切除术中神经监测及机械性损伤的影响

Effects of cisatracurium and rocuronium on intraoperative neuromonitoring and putuative mechanical trauma in 500 robotic baba thyroidectomies.
PubMed 文献 · Surg Endosc · 2026-09-22

该回顾性研究分析了500例机器人BABA甲状腺切除术伴术中神经监测(IONM)的患者,比较三种神经肌肉阻滞方案对插管条件、肌电信号及喉返神经(RLN)损伤的影响。结果显示低剂量顺阿曲库铵0.05 mg/kg插管条件优良、肌电信号稳定,暂时性RLN麻痹率2.4%且6个月内完全恢复,无永久性麻痹。

要点

  • 低剂量顺阿曲库铵0.05 mg/kg可提供优良插管条件与稳定肌电信号。
  • 该组暂时性RLN麻痹率2.4%,6个月内完全恢复,无永久性麻痹。
  • 较高剂量顺阿曲库铵及罗库溴铵0.3 mg/kg结果相似但样本量小,属探索性。

核心结论

  • 在机器人BABA甲状腺切除术伴IONM中,单次低剂量顺阿曲库铵0.05 mg/kg插管条件优良、肌电信号稳定、RLN并发症低,无证据表明缺乏力反馈会增加机械性损伤。

研究设计与样本

  • 按诱导时神经肌肉阻滞方案分为三组:A组顺阿曲库铵0.05 mg/kg(n=459)、B组顺阿曲库铵0.1 mg/kg(n=20)、C组罗库溴铵0.3 mg/kg(n=21)。

主要发现

  • 所有组插管条件均为优良或良好。
  • V1、R1、R2、V2平均肌电振幅均处于可靠IONM所需范围,组间无显著差异。
  • A组暂时性RLN麻痹发生率为2.4%,6个月内完全恢复,无永久性RLN麻痹;B组和C组无RLN损伤记录,但样本量小。
  • 顺阿曲库铵0.05 mg/kg组拔管时血压和心率波动小于0.1 mg/kg组。
  • 引流液量、疼痛评分、美容满意度和住院时间组间相当。

临床怎么用

  • 机器人BABA甲状腺切除术伴IONM时,可考虑采用低剂量顺阿曲库铵0.05 mg/kg作为符合指南的神经肌肉阻滞策略。

局限性

  • 回顾性设计。
  • B组和C组样本量小,结果应视为探索性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In thyroid surgery with intraoperative neuromonitoring (IONM), guidelines recommend a single intubating dose of neuromuscular blocking agent (NMBA) close to 1 × ED95 to balance intubation conditions and reliable electromyographic (EMG) signals. In robotic bilateral axillo-breast approach (BABA) thyroidectomy, however, the absence of haptic feedback raises concerns that persistent muscle relaxation could favor unrecognized mechanical trauma to the recurrent laryngeal nerve (RLN). METHODS: We retrospectively analyzed consecutive patients undergoing elective robotic BABA thyroidectomy with IONM between April 2020 and October 2022. Patients received one of three NMBA regimens at induction: cisatracurium 0.05 mg/kg (group A), cisatracurium 0.1 mg/kg (group B), or rocuronium 0.3 mg/kg (group C). We compared intubation conditions, hemodynamics, anesthetic requirements, RLN and vagus EMG amplitudes (V1, R1, R2, V2), and perioperative outcomes, including RLN palsy, drainage, pain, and hospital stay. RESULTS: Five hundred robotic BABA thyroidectomies were included (group A: n = 459; group B: n = 20; group C: n = 21). Across all groups, intubation conditions were consistently excellent or good. Mean EMG amplitudes for V1, R1, R2, and V2 remained within the range considered adequate for reliable IONM, with no significant differences between NMBA regimens. In group A, transient RLN palsy occurred in 2.4% of patients and resolved completely by 6 months; no permanent RLN palsy was observed. No RLN injuries were recorded in groups B and C, although these cohorts were small. Hemodynamic profiles were generally stable; cisatracurium 0.05 mg/kg was associated with less fluctuation in blood pressure and heart rate at extubation compared with cisatracurium 0.1 mg/kg. Drainage volumes, pain scores, cosmetic satisfaction, and hospital stay were comparable among groups. CONCLUSIONS: In robotic BABA thyroidectomy with IONM, a single low dose of cisatracurium 0.05 mg/kg provides excellent intubation conditions, stable EMG signals, and low RLN morbidity, without evidence of increased mechanical trauma despite the lack of force feedback. Higher cisatracurium dose and rocuronium 0.3 mg/kg yielded similar EMG and clinical outcomes in this series, but should be interpreted as exploratory due to small sample size. These findings support low-dose cisatracurium as a practical, guideline-consistent NMBA strategy for robotic thyroid surgery with IONM.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zhang D, Fan X, Yang M, et al. Effects of cisatracurium and rocuronium on intraoperative neuromonitoring and putuative mechanical trauma in 500 robotic baba thyroidectomies. Surg Endosc. 2026. PMID: 42773262. doi:10.1007/s00464-026-13358-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。